Predictive factors for anemia response to erythropoiesis-stimulating agents in myelofibrosis-Reference-Cited by-同舟云学术

Predictive factors for anemia response to erythropoiesis-stimulating agents in myelofibrosis

Published:2017-01-19 Issue:4 Volume:98 Page:407-414
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:Eur J Haematol

Author:

Hernández-Boluda Juan-Carlos¹,Correa Juan-Gonzalo²,García-Delgado Regina³,Martínez-López Joaquín⁴,Alvarez-Larrán Alberto⁵,Fox María-Laura⁶,García-Gutiérrez Valentín⁷,Pérez-Encinas Manuel⁸,Ferrer-Marín Francisca⁹,Mata-Vázquez María-Isabel¹⁰,Raya José-María¹¹,Estrada Natalia¹²,García Silvia¹³,Kerguelen Ana¹⁴,Durán María-Antonia¹⁵,Albors Manuel¹⁶,Cervantes Francisco²

Affiliation:

1. Hematology Department; Hospital Clínico Universitario; INCLIVA; Valencia Spain

2. Hematology Department; Hospital Clínic; IDIBAPS; University of Barcelona; Barcelona Spain

3. Hematology Department; Hospital Virgen de la Victoria; Málaga Spain

4. Hematology Department; Hospital 12 de Octubre; Madrid Spain

5. Hematology Department; Hospital del Mar; Barcelona Spain

6. Hematology Department; Hospital Vall d'Hebron; Barcelona Spain

7. Hematology Department; Hospital Ramón y Cajal; Madrid Spain

8. Hematology Department; Hospital Clínico; Santiago de Compostela Spain

9. Hematology and Medical Oncology Department; Hospital Morales Meseguer; IMIB-Arrixaca; UCAM; Murcia Spain

10. Hematology Department; Hospital Costa del Sol; Marbella Spain

11. Hematology Department; Hospital Universitario de Canarias; Tenerife Spain

12. Hematology Department; Institut Català d'Oncologia-Hospital Germans Trias i Pujol; Josep Carreras Leukemia Research Institute; Badalona Spain

13. Hematology Department; Hospital La Fe; IIS La Fe; Valencia Spain

14. Hematology Department; Hospital La Paz; Madrid Spain

15. Hematology Department; Hospital Son Espases; Mallorca Spain

16. Hematology Department; Complexo Hospitalario Universitario de Ourense; Ourense Spain

Funder

Instituto de Salud Carlos III

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ejh.12846/fullpdf

Reference28 articles.

1. Pathogenesis of myelofibrosis with myeloid metaplasia;Tefferi;J Clin Oncol,2005

2. Recent advances in understanding myelofibrosis and essential thrombocythemia;Vainchenker;F1000Res,2016

3. How I treat myelofibrosis;Cervantes;Blood,2014

4. Prognostication in primary myelofibrosis;Cervantes;Curr Hematol Malig Rep,2012

5. Alleviating anemia and thrombocytopenia in myelofibrosis patients;Cervantes;Expert Rev Hematol,2016

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SOHO State of the Art Updates and Next Questions | Choosing and Properly Using a JAK Inhibitor in Myelofibrosis;Clinical Lymphoma Myeloma and Leukemia;2024-09

2. Safety and efficacy of luspatercept for the treatment of anemia in patients with myelofibrosis;Blood Advances;2024-08-28

3. Les inhibiteurs de JAK en médecine interne;La Revue de Médecine Interne;2024-06

4. Advances in pharmacotherapy for myelofibrosis: what is the current state of play?;Expert Opinion on Pharmacotherapy;2024-04-12

5. Momelotinib in myelofibrosis;Expert Opinion on Pharmacotherapy;2024-03-23